Agios Pharmaceuticals (AGIO) News Today $35.22 +1.47 (+4.34%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$35.22 +0.00 (+0.01%) As of 02/21/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Agios Pharmaceuticals (NASDAQ:AGIO) Releases Quarterly Earnings Results, Misses Estimates By $0.05 EPSAgios Pharmaceuticals (NASDAQ:AGIO - Get Free Report) issued its quarterly earnings results on Thursday. The biopharmaceutical company reported ($1.74) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.69) by ($0.05). Agios Pharmaceuticals had a net margin of 1,845.92% and a negative return on equity of 2.51%.February 21 at 11:20 AM | marketbeat.comAgios to Present at the TD Cowen 45th Annual Healthcare Conference on March 3, 2025February 20 at 7:00 AM | globenewswire.comAgios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q4 2024 Earnings Call TranscriptFebruary 19 at 9:20 AM | insidermonkey.comAgios Pharmaceuticals, Inc. (NASDAQ:AGIO) Short Interest Down 6.0% in JanuaryAgios Pharmaceuticals, Inc. (NASDAQ:AGIO - Get Free Report) was the target of a large decline in short interest in the month of January. As of January 31st, there was short interest totalling 5,030,000 shares, a decline of 6.0% from the January 15th total of 5,350,000 shares. Based on an average daily trading volume, of 882,500 shares, the days-to-cover ratio is currently 5.7 days. Approximately 9.1% of the shares of the company are short sold.February 18, 2025 | marketbeat.comStockNews.com Downgrades Agios Pharmaceuticals (NASDAQ:AGIO) to SellFebruary 17, 2025 | americanbankingnews.comAgios Pharmaceuticals (NASDAQ:AGIO) Stock Rating Lowered by StockNews.comStockNews.com lowered shares of Agios Pharmaceuticals from a "hold" rating to a "sell" rating in a research report on Friday.February 15, 2025 | marketbeat.comScotiabank Sticks to Its Buy Rating for Agios Pharma (AGIO)February 14, 2025 | markets.businessinsider.comAgios Pharmaceuticals price target lowered to $74 from $75 at ScotiabankFebruary 14, 2025 | markets.businessinsider.comAgios Pharmaceuticals: Liver Toxicity Issues May Threaten Thalassemia Approval (Rating Downgrade)February 14, 2025 | seekingalpha.comAgios Pharmaceuticals Inc (AGIO) Q4 2024 Earnings Call Highlights: Robust Revenue Growth and ...February 14, 2025 | finance.yahoo.comAgios Pharmaceuticals reports results from Phase 3 ACTIVATE-Kids studyFebruary 13, 2025 | markets.businessinsider.comEarnings call transcript: Agios Pharm Q4 2024 beats EPS forecast, stock risesFebruary 13, 2025 | msn.comAgios Pharmaceuticals reports Q4 revenue $10.7M, consensus $9.35MFebruary 13, 2025 | markets.businessinsider.comAgios Pharmaceuticals targets multi-billion-dollar growth with Pyrukynd expansion in 2025February 13, 2025 | msn.comAgios Pharmaceuticals, Inc. (AGIO) Q4 2024 Earnings Call TranscriptFebruary 13, 2025 | seekingalpha.comAgios Pharmaceuticals, Inc. 2024 Q4 - Results - Earnings Call PresentationFebruary 13, 2025 | seekingalpha.comAgios Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business HighlightsFebruary 13, 2025 | globenewswire.comAgios' Phase 3 ACTIVATE-Kids Study of Mitapivat in Children with Pyruvate Kinase (PK) Deficiency Not Regularly Transfused Met Primary EndpointFebruary 13, 2025 | globenewswire.comRep. Gilbert Ray Cisneros, Jr. Buys Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) StockRepresentative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO). In a filing disclosed on February 11th, the Representative disclosed that they had bought between $1,001 and $15,000 in Agios Pharmaceuticals stock on January 29th. The tradeFebruary 13, 2025 | marketbeat.comAgios Pharmaceuticals (AGIO) Expected to Announce Quarterly Earnings on ThursdayAgios Pharmaceuticals (NASDAQ:AGIO) will be releasing earnings before the market opens on Thursday, February 20, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=661768)February 13, 2025 | marketbeat.comAgios Pharmaceuticals, Inc. (AGIO): A Cheap Biotech Stock to Invest In NowFebruary 12, 2025 | uk.finance.yahoo.comFY2024 Earnings Forecast for AGIO Issued By Leerink PartnrsFebruary 12, 2025 | americanbankingnews.comC4 Therapeutics stock plunges to 52-week low of $3.24February 11, 2025 | msn.comAgios Pharmaceuticals price target lowered to $54 from $55 at BofAFebruary 11, 2025 | markets.businessinsider.comAgios Pharmaceuticals (NASDAQ:AGIO) Shares Gap Down - Here's What HappenedAgios Pharmaceuticals (NASDAQ:AGIO) Shares Gap Down - Here's WhyFebruary 11, 2025 | marketbeat.comCrispr Therapeutics AG (CRSP) Gets a Buy from Bank of America SecuritiesFebruary 11, 2025 | markets.businessinsider.comBank of America Securities Keeps Their Buy Rating on Agios Pharma (AGIO)February 11, 2025 | markets.businessinsider.comLeerink Partnrs Has Strong Forecast for AGIO FY2024 EarningsAgios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) - Research analysts at Leerink Partnrs boosted their FY2024 earnings per share (EPS) estimates for Agios Pharmaceuticals in a report issued on Wednesday, February 5th. Leerink Partnrs analyst A. Berens now anticipates that the biopharmaceutiFebruary 10, 2025 | marketbeat.comAgios Pharmaceuticals principal accounting officer sells shares for $78,134February 5, 2025 | msn.comShort Interest in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Increases By 8.0%Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Get Free Report) saw a significant increase in short interest in the month of January. As of January 15th, there was short interest totalling 5,530,000 shares, an increase of 8.0% from the December 31st total of 5,120,000 shares. Currently, 10.0% of the shares of the company are short sold. Based on an average trading volume of 831,700 shares, the days-to-cover ratio is currently 6.6 days.February 2, 2025 | marketbeat.comAgios Pharmaceuticals, Inc. (NASDAQ:AGIO) Receives Average Recommendation of "Moderate Buy" from AnalystsAgios Pharmaceuticals, Inc. (NASDAQ:AGIO - Get Free Report) has received an average recommendation of "Moderate Buy" from the eight ratings firms that are covering the stock, Marketbeat reports. Four research analysts have rated the stock with a hold rating and four have issued a buy rating on thJanuary 30, 2025 | marketbeat.comAgios Pharma (AGIO) Gets a Buy from Bank of America SecuritiesJanuary 16, 2025 | markets.businessinsider.comY-Mabs Therapeutics (YMAB) Gets a Hold from Bank of America SecuritiesJanuary 16, 2025 | markets.businessinsider.comCrispr Therapeutics AG (CRSP) Receives a Buy from Bank of America SecuritiesJanuary 15, 2025 | markets.businessinsider.comAgios Pharmaceuticals: Considering Risk/Reward Ahead Of FDA DecisionJanuary 14, 2025 | seekingalpha.comAgios Pharmaceuticals announces key 2025 milestones, catalysts through 2026January 13, 2025 | msn.comAgios Announces Key 2025 Milestones for Innovative Rare Disease PortfolioJanuary 13, 2025 | finance.yahoo.comAgios Pharmaceuticals (NASDAQ:AGIO) Stock Price Down 7.5% - Should You Sell?Agios Pharmaceuticals (NASDAQ:AGIO) Stock Price Down 7.5% - Should You Sell?January 10, 2025 | marketbeat.comRBC Capital Sticks to Its Buy Rating for Agios Pharma (AGIO)January 10, 2025 | markets.businessinsider.comAgios Pharmaceuticals announces FDA accepted sNDA for PYRUKYNDJanuary 9, 2025 | markets.businessinsider.comFDA To Decide On Agios' Request For Expanded Approval Of PYRUKYND In Thalassemia By September 7.January 9, 2025 | markets.businessinsider.comInsider Selling: Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Insider Sells 2,804 Shares of StockJanuary 8, 2025 | insidertrades.comAgios Pharmaceuticals, Inc. (NASDAQ:AGIO) Insider Sells 2,804 SharesAgios Pharmaceuticals, Inc. (NASDAQ:AGIO - Get Free Report) insider Tsveta Milanova sold 2,804 shares of the company's stock in a transaction on Monday, January 6th. The shares were sold at an average price of $32.18, for a total value of $90,232.72. Following the completion of the transaction, the insider now directly owns 18,906 shares in the company, valued at $608,395.08. This represents a 12.92 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.January 7, 2025 | marketbeat.comBank of America Securities downgrades Bioxcel Therapeutics (BTAI) to a SellJanuary 7, 2025 | markets.businessinsider.comAgios Pharmaceuticals price target lowered to $55 from $60 at BofAJanuary 7, 2025 | markets.businessinsider.comThe Robot Portfolio Gained 22% In 2024January 7, 2025 | forbes.comAgios Pharmaceuticals (NASDAQ:AGIO) Sees Strong Trading Volume - What's Next?Agios Pharmaceuticals (NASDAQ:AGIO) Sees Strong Trading Volume - Should You Buy?January 6, 2025 | marketbeat.comAgios Pharmaceuticals, Inc. (NASDAQ:AGIO) Receives Average Rating of "Moderate Buy" from BrokeragesShares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the eight research firms that are covering the firm, MarketBeat.com reports. Four research analysts have rated the stock with a hold rating and four have issuedJanuary 5, 2025 | marketbeat.comJPMorgan Chase & Co. Sells 63,155 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)JPMorgan Chase & Co. cut its holdings in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 3.6% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,712,990 shares of the biopharmaceutical company's stock afJanuary 4, 2025 | marketbeat.comAgios to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025January 3, 2025 | globenewswire.com Get Agios Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AGIO and its competitors with MarketBeat's FREE daily newsletter. Email Address AGIO Media Mentions By Week AGIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AGIO News Sentiment▼0.120.60▲Average Medical News Sentiment AGIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AGIO Articles This Week▼85▲AGIO Articles Average Week Get Agios Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AGIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Revolution Medicines News Legend Biotech News BridgeBio Pharma News Axsome Therapeutics News Blueprint Medicines News Telix Pharmaceuticals Limited American Depositary Shares News Elanco Animal Health News Lantheus News Nuvalent News Cytokinetics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AGIO) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Agios Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Agios Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AGIO Stock Alerts